:: Class Utilisation Summary 2016
See LEGEND for key to shading and symbols.
:: Subject Area - PHAR Term - Semester 2
PHAR2011 | PHAR2211 | PHAR3101 | PHAR3202 | PHAR3306 | PHAR9103 |
PHAR9104 | PHAR9109 | PHAR9116 | PHAR9117 | PHAR9120 |
Data is correct as at Tue Oct 11 19:05:29 AEDT 2016
Comp | Sect | Class | Type | Status | Enr/Cap | % Full | Times (weeks, Location) - default 1hour |
PHAR2011 | Introductory Pharmacology and | ||||||
LAB | M10A | 3332 | Enr | Open | 93/100 | 93% | Mon 10-13 (w1-2,4,6,8,12, Wurth 115) |
LAB | M10B | 3333 | Enr | Open | 90/100 | 90% | Mon 10-13 (w1, Wurth 115); Mon 10-13 (w3,5,7,9,11, Wurth 115) |
LAB | M14A | 3334 | Enr | Open | 58/100 | 58% | Mon 14-17 (w1,3,5,7,9,11, Wurth 115) |
LEC | A | 3331 | Rel | Open | 241/300 | 80% | Tue 13 (w1-9,10-12, Burrows Th); Wed 13 (w1-9,10-12, Science Th) Comb/w PHAR2211 |
TUT | T14A | 3339 | Rel | Full | 50/50 | 100% | Tue 14 (w2-9,10-13, Mat 107) |
TUT | T14B | 3340 | Rel | Open | 49/50 | 98% | Tue 14 (w2-9,10-13, Mat 123) |
TUT | W15A | 3335 | Rel | Open | 49/50 | 98% | Wed 15 (w2-9,10-13, Mat 107) |
TUT | W15B | 3336 | Rel | Open | 48/50 | 96% | Wed 15 (w2-9,10-13, Mat 123) |
TUT | W16A | 3337 | Rel | Open | 25/50 | 50% | Wed 16 (w2-9,10-13, Mat 123) |
TUT | W16B | 3338 | Rel | Open | 20/50 | 40% | Wed 16 (w2-9,10-13, Mat 107) |
PHAR2211 | Pharmacology for HESC | ||||||
LAB | M14A | 6082 | Enr | Open | 77/95 | 81% | Mon 14-17 (w1-2,4,6,8,12, Wurth 115) |
LEC | A | 6081 | Rel | Open | 77/95 | 81% | Tue 13 (w1-9,10-12, Burrows Th); Wed 13 (w1-9,10-12, Science Th) Comb/w PHAR2011 |
SEM | H09A | 6083 | Rel | Open | 77/95 | 81% | Thu 09-11 (w2-9,10-13, WurthLG03) |
PHAR3101 | Drug Discovery, Design & Devel | ||||||
LAB | W15A | 4346 | Enr | Open | 43/50 | 86% | Wed 15-18 (w2-9,10-13, Wurth 115) |
LEC | A | 4345 | Rel | Open | 43/50 | 86% | Tue 12 (w1-9,10-12, WurthLG02); Wed 13 (w1-9,10-12, WurthLG02) |
TUT | H11A | 4347 | Rel | Open | 19/25 | 76% | Thu 11 (w2-9,10-13, G27 LG06) |
TUT | H12A | 4348 | Rel | Open | 24/25 | 96% | Thu 12 (w2-9,10-13, G27 LG06) |
PHAR3202 | Neuropharmacology | ||||||
LAB | H09A | 5697 | Enr | Open | 26/30 | 87% | Thu 09-12 (w2-9,10-13, Wurth 120) |
LAB | H14A | 5698 | Enr | Open | 26/30 | 87% | Thu 14-17 (w2-9,10-13, Wurth 120) |
LEC | A | 5696 | Rel | Open | 52/60 | 87% | Mon 17 (w1-9,10-12, WurthLG03); Wed 10 (w1-9,10-12, WurthLG03) |
TUT | M11A | 5699 | Rel | Tent | 0/0 | N/A | Mon 11 (w2-9,10-13, CivEng G6) |
TUT | M12A | 5700 | Rel | Open | 29/30 | 97% | Mon 12 (w2-9,10-13, Mat 231) |
TUT | M13A | 5701 | Rel | Open | 23/30 | 77% | Mon 13 (w2-9,10-13, Mat 113) |
PHAR3306 | Pharmacology for Optometry | ||||||
LAB | H15A | 5703 | Enr | Open | 76/98 | 78% | Thu 15-18 (w8, Wurth 115); Thu 15-18 (w2-3,5,7,9,11, WurthG07) |
LEC | A | 5702 | Rel | Open | 76/98 | 78% | Mon 14 (w1-9,10-12, WurthLG03); Wed 16-18 (w1-9,10-12, WurthLG03) |
TUT | H14A | 5704 | Rel | Full | 33/33 | 100% | Thu 14 (w4,6,10, Mat 307) |
TUT | H15B | 5705 | Rel | Open | 31/33 | 94% | Thu 15 (w4,6,10, Mat 307) |
TUT | H16A | 5706 | Rel | Open | 12/33 | 36% | Thu 16 (w4,6,10, Mat 307) |
PHAR9103 | Biostatistics and Trial Design | ||||||
DST | 03 | 1305 | Enr | Open | 2/25 | 8% | |
PHAR9104 | Legal/Regulatory Devlp of Med | ||||||
DST | 04 | 1306 | Enr | Open | 19/30 | 63% | |
PHAR9109 | Therapeutic Basis of Drug Use | ||||||
DST | 09 | 1307 | Enr | Open | 5/30 | 17% | |
PHAR9116 | Advanced Clinical Trials Mgmt | ||||||
DST | 16 | 1308 | Enr | Open | 0/30 | 0% | |
PHAR9117 | Cancer Therapeutics | ||||||
DST | 17 | 1309 | Enr | Open | 8/30 | 27% | |
PHAR9120 | Clinical Development of Med | ||||||
DST | 20 | 1310 | Enr | Open | 13/30 | 43% | |
^ top ^ | |||||||
LEGEND | |||||||
* This class requires consent. Students cannot self-enrol. | |||||||
# Timetable clash allowed. | |||||||
/odd Runs in odd weeks only. /even Runs in even weeks only. | |||||||
Comb/w Jointly taught with corresponding class(es) for specified course(s). Capacity shown is effective capacity. | |||||||
Effective capacity is the class capacity less any places taken by students in the other jointly-taught classes. | |||||||
[ ] Class capacity where different from effective capacity. | |||||||
Shaded cells: | LEC | Activity different from previous | |||||
Stop | Status is Stop Further Enrolment, Tentative, Closed or Cancelled | ||||||
100% | Class is full (> 100% means capacity is exceeded) | ||||||
80% | Class is nearly full (80% or more) | ||||||
50% | Class is half full | ||||||
0% | Class is less than half full | ||||||
UNSW Sydney NSW 2052, Australian Telephone: (within Aust) 02 9385 1000, (International) +61 2 9385 1000 CRICOS Provider Code 00098G Authorised by Deputy Vice Chancellor (Academic) & Registrar Privacy Statement Copyright & Disclaimer |